Skip to main content
Metallomix

Thank you for considering to support our clinical path to meaningful therapeutic innovation

We are grateful that you see the value in our work and are willing to support it despite the lack of tax advantages and high risk. Your decision to participate in the funding of an innovation long before it is “de‑risked” enough for venture capital is both rare and courageous. So, your support matters deeply. Thank you.

Our "Thank You" Note

You are backing a team willing to shoulder uncomfortable levels of risk to pursue potentially transformative clinical outcomes. Thank you for standing with us, and for giving us a chance.

Our Promise of Giving Back

When and if our high-risk clinical trials are successful, and if FDA approves the drugs we develop, we promise to match the donation amount to provide these drugs to uninsured patients in need, free of charge.

Our Accountability

Your money will allow us to explore the ideas that could fundamentally change how we treat and prevent diseases. We will report our progress through our SEC filings and our LinkedIn corporate page.

"Too Risky" For Investing

You help finance clinical research that investors view as “too risky”—not because the science is weak, but because most similar attempts have historically failed. 

Preventing Diseases

Preventing disease is not considered a therapeutic goal, simply because the disease is not yet symptomatic and cannot be diagnosed. We disagree.

Philanthropic Investing

If you are a philanthropic investor, a venture capitalist willing to take high risk, or a grantor, please contact us via email or LinkedIn. Either way, thank you.